Skip to content

Why we should all be thrilled about the FDA starting to embrace innovation

March 3, 2015

On Feb. 19, the U.S. Food and Drug Administration took a huge step towards patient-centric medicine when it approved the marketing of genetics testing company 23andMe’s carrier test for Bloom…

Source: singularityhub.com

Hopefully FDA granting permission to 23andMe to sell genetic test for one serious disease is only the beginning. I am able to handle finding out my own genetic propensities, thank you very much. Give me the information and I will decide what to do with it.

See on Scoop.itNew Space

Advertisements
No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: